Press Releases

11/18/16 12:30 pm EST
Tenax Therapeutics Announces Completion of Enrollment for Phase 3 LEVO-CTS Trial in Cardiac Surgery
11/10/16 6:00 am EST
Tenax Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update
11/09/16 4:20 pm EST
Investor Calendar Invites You to the Tenax Therapeutics Third Quarter 2016 Business Review and Update on Thursday, November 10, 2016
11/03/16 4:30 pm EDT
Tenax Therapeutics to Discuss Third Quarter 2016 Financial Results and Provide Business Update
10/05/16 10:30 am EDT
Tenax Therapeutics Provides Clinical Update for Lead Candidate Levosimendan
08/11/16 6:00 am EDT
Tenax Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
08/03/16 5:00 pm EDT
Tenax Therapeutics to Discuss Second Quarter 2016 Financial Results and Provide Business Update
05/19/16 6:30 am EDT
Tenax Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update
05/10/16 7:30 am EDT
 Tenax Therapeutics to Discuss First Quarter 2016 Financial Results and Provide Business Update
03/16/16 6:00 am EDT
Tenax Therapeutics Announces 2015 Transitional Report and Provides Corporate Update
03/09/16 5:30 pm EST
Tenax Therapeutics to Provide 2015 Transitional Report and Business Update
03/01/16 5:30 pm EST
Tenax Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
02/04/16 7:30 am EST
Tenax Therapeutics to Present at Leerink Partners 5th Annual Global Healthcare Conference
02/01/16 7:30 am EST
Tenax Therapeutics Provides Update of Phase 3 LEVO-CTS Trial for LCOS